Surge Company

Surge is an immunological model capable of predicting postoperative infections. The company combines a single-cell assessment of the immune system before surgery with clinical data using a proprietary machine-learning algorithm. By analyzing the millions of immune cells in a small amount of blood, the platform can mimic surgical trauma in a test tube before surgery.


Investors

Headquarters: Illkirch-graffenstaden,Alsace,France,Europe
Employee Number: 11-50
Industry: Immuno-Virotherapies
Number Of Exists: 1
Founded Date: 2021-01-01
Funding Status: private